Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Development status updated for 3M's imiquimod analogue R-848

Oct. 7, 1998

La Jolla enrolls patients in phase II/III trial for lupus treatment

Oct. 6, 1998

Ono discloses compounds with high binding affinity for prostanoid EP4 receptors

Oct. 6, 1998

Chiroscience identifies new target for autoimmune disease therapy

Oct. 5, 1998

Merck describes new ascomycin derivatives with improved therapeutic potential

Oct. 5, 1998

3M presents first clinical results for potent new immunomodulator

Oct. 5, 1998

Major pediatric study supports safety and efficacy of pneumococcal vaccine

Oct. 1, 1998

Aviron presents new clinical data for FluMist at ICAAC

Oct. 1, 1998

New study shows that LYMErix can be given according to a flexible dosing schedule

Sep. 30, 1998

Pierre Fabre obtains good results with RSV subunit vaccine in monkey model

Sep. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...